达普罗多斯塔特对腹腔透析患者铁代谢的影响:一项探索性研究
Tomohiro Yan1, Yukinao Sakai2, Shunnosuke Kunoki1
1Department of Endocrinology, Metabolism and Nephrology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Blood purification
|October 4, 2025
概括
在腹腔透析患者中,达普罗杜沙特显示出改善铁代谢和减少氧化应激的潜力,但没有显著提高血红蛋白水平. 需要进一步的研究来证实它在这个人群中的有效性和安全性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 脏贫血是慢性病 (CKD) 患者的重要并发症.
- 达普罗杜斯塔特是一种低氧诱导因子-基酶抑制剂,是贫血的潜在治疗方法.
- 它对腹膜透析 (PD) 患者的影响尚不清楚.
研究的目的:
- 探索达普罗杜斯塔特在接受维护PD的CKD患者中的初步效果.
- 评估血液学参数的变化,铁代谢,心脏功能和氧化应激.
主要方法:
- 这是一项单一中心前性研究,涉及11名PD患者.
- 患者从达布洛素α转换为达普罗杜沙特.
- 监测持续了24周,分析了各种生物标志物.
主要成果:
- 肝素-25和氧化低密度脂蛋白水平显著下降.
- 铁结合能力和网细胞数量显著增加.
- 血红蛋白或血红素水平没有显著改善;心脏功能保持稳定.
结论:
- 达普罗杜沙特可以改善铁代谢,减少PD患者的氧化应激.
- 在这项试点研究中,该药物没有显著改善血红蛋白水平.
- 较大的随机试验是必要的,以证实有效性和安全性,由于样本小,随访时间短等局限性.
相关概念视频
Peritoneal Dialysis III: Nursing Management
656
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
656
Peritoneal Dialysis I: Introduction and Procedure
2.3K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
2.3K
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
534
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
534
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
253
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
253
Chronic Kidney Disease III: Interprofessional Care
339
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
339
Renal Failure: Dose Adjustments
437
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
437


